Hiroshi Katoh
8PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 24, 2025
Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.Hiroshi Katoh, Riku Okamoto, Yuka Ozawa
|Nov 13, 2025
Comparative Oncology: Cross-Sectional Single-Cell Transcriptomic Profiling of the Tumor Microenvironment Across Seven Human Cancers.Riku Okamoto, Kota Okuno, Akiko Watanabe
|Sep 18, 2025
Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion.Hiroshi Katoh, Riku Okamoto, Yuka Ozawa
|Jun 23, 2025
Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.Riku Okamoto, Hiroshi Katoh, Kanako Naito
|Jul 10, 2024
Pembrolizumab with external radiation therapy effectively controlled TMB-high unresectable recurrent parathyroid cancer: a case report with review of literature.Hiroshi Katoh, Tomoya Mitsuma, Riku Okamoto
|Mar 05, 2024
Correction: The Usefulness of AirSeal™ Intelligent Flow System in Gas Insufflation Total Endoscopic Thyroidectomy.Hiroshi Katoh, Yoshifumi Ikeda, Yoshiyuki Saito
Pageof 2
